Vida Ventures, LLC

29 employees

Vida Ventures is a next-generation life sciences investment firm .

Investor insights

Sectors invested in

Biotechnology39

Health Care23

Therapeutics19

Medical15

Pharmaceutical11

Biopharma10

Life Science10

Genetics4

Medical Device4

Chemical3

cell therapy3

Genetic Respiratory Disease3

Non-Viral Lipid Nanoparticles3

Genetic Medicines3

RNA Therapies3

Cystic Fibrosis3

Primary Ciliary Dyskinesia3

lupus2

Alternative Medicine2

Drug Discovery2

Funding rounds participated in

$1M sweet spot round size

Most of their 43 investments are in rounds between $62M and $115M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Venture Capital

Date founded

2017

Investments made

Avalyn Pharma Inc. raised $175M on September 27, 2023

Investors: Surveyor Capital, Novo Holdings, S.R. One Ltd, Wellington Management, RiverVest Venture Partners, Perceptive Advisors and Vida Ventures, LLC

ReCode Therapeutics raised $50M on September 19, 2023

Investors: Sanofi Ventures, OrbiMed Advisors, Solasta Ventures, Leaps by Bayer, Osage University Partners (OUP), MPM Capital and Vida Ventures, LLC

Quanta Therapeutics raised $51M on May 22, 2023

Investors: Sofinnova Ventures, Russia technology fund, Longitude Capital, Avidity Partners, Surveyor Capital and Vida Ventures, LLC

Volastra Therapeutics raised $60M on March 7, 2023

Investors: Polaris Partners, -, Catalio Capital Management, ARCH Venture Partners and Vida Ventures, LLC

Capstan Therapeutics raised $102M on September 14, 2022

Investors: Bristol-Myers Squibb, UK, RA Capital Management, L.P., Leaps by Bayer, Polaris Partners, OrbiMed Advisors and Vida Ventures, LLC

Aktis Oncology raised $84M on August 25, 2022

Investors: Octagon Capital Advisors, NS Investment, Pappas Capital, TCG X, MPM Capital, Merck Group and Vida Ventures, LLC

Affini-T Therapeutics raised $175M on March 22, 2022

Investors: Parker Institute for Cancer Immunotherapy, Humboldt Fund, Leaps by Bayer, fred hutch, Agent Capital, Catalio Capital Management, - and Vida Ventures, LLC

Kyverna Therapeutics raised $85M on January 26, 2022

Investors: LYFE Capital, Hudson Bay Capital Management LP, Westlake Village BioPartners®, Intellia Therapeutics, Inc., Insight Partners, RTW Investments, LP, Northpond Ventures and Vida Ventures, LLC

Capstan Therapeutics raised $63M on November 1, 2021

Investors: OrbiMed Advisors, RA Capital Management, L.P. and Vida Ventures, LLC

Quanta Therapeutics raised $60M on October 26, 2021

Investors: Logos Global Management, LP, Surveyor Capital, Longitude Capital, Sofinnova Ventures, Russia technology fund and Vida Ventures, LLC